1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 2:Distribution of variant VA entries to the FT in an enriched sample of all 125 cases with variant VAsa
RVA (%) LVA (%) Single origins C3 2 (3.6%) 1 (1.2%) C4 14 (25.4%) 11 (13.6%) C5 31 (56.4%) 47 (55.6%) C7 7 (12.7%) 24 (28.9%) Thoracic 1 (1.8%) 0 (0%) Multiple origins C3, C6 1 (8.3%) 0 (0%) C4, C6 7 (58.3%) 2 (16.7%) C5, C6 1 (8.3%) 1 (8.3%) C4, C5, C6 1 (8.3%) 0 (0%)
↵a This sample includes the consecutive sample described earlier as well as an additional set of selected variants that were encountered outside of the sampling period.